Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy.

By E. Tsochatzis, K. Gurusamy, S. Ntaoula, E. Cholongitas, B. Davidson, Andrew K. Burroughs. Journal of Hepatology, 2011

742 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Physiology

View Paper: https://www.semanticscholar.org/paper/e316d4e512204f2e78c51c8659b7263ecd73507f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Asociacion Latinoamericana para el Estudio del Higado
2. Laurent Castéra
3. M. Kudo
4. A. Berzigotti

In Hepatology

1. Asociacion Latinoamericana para el Estudio del Higado
2. M. Kudo
3. F. Piscaglia
4. Laurent Castéra
5. A. Berzigotti

In Physiology

1. Asociacion Latinoamericana para el Estudio del Higado

Citations in the corpus

• WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, background): “However, only 9 studies (1364 patients) had acceptable standards for both liver biopsy and TE, which limits the conclusions (Tsochatzis et al. 2011).”
• EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017, background): “In patients with CHC, TE can differentiate absent and mild fibrosis from significant fibrosis and cirrhosis, but is not accurate enough to distinguish between separate stages of fibrosis (F1 – F4) [147 – 149].”
• Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. (2019, neutral): “53] CK18-M30 (IU/L) 369 415 [395] [74–1825] Time between FibroScan and liver biopsy (d) 383 0 [7] [0–14] XL probe 383 255 (67) –”
• EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, positive): “Several meta-analyzes [145–149] have confirmed the better diagnostic performance of TE for cirrhosis than for fibrosis, with mean AUROC values of 0.”
• EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications (2013, positive): “It was initially evaluated in patients with chronic hepatitis C and later in other chronic hepatopathies [17 – 19].”
• Determination of reliability criteria for liver stiffness evaluation by transient elastography (2013, methodology): “LSE diagnostic cutoffs calculated in published studies are very heterogeneous.(28) We tested several cutoffs, some calculated for CHC(12-14) and others determined in a large meta-analysis including patients with various causes of chronic liver disease.”
• EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. (2012, background): “Transient elastography, which is a non-invasive method widely used in Europe, offers high diagnostic accuracy for the detection of cirrhosis, although the results may be confounded by severe inflammation associated with high ALT levels and the optimal cut-off of liver stiffness measurements vary amo”